TLTilray Brands, Inc. TLRY · NASDAQ
$2.53 -4.17% (-$0.11)
- Market cap
- $295.2M
- Enterprise value
- $384.3M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.3x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -4.7%
- Gross margin
- 28.2%
- Net margin
- -16.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.92
- Free float
- 120.1%
About the company
Tilray Brands, Inc. is an international company specializing in the production and distribution of medicinal cannabis products and related goods. The company focuses on the cultivation, processing, and manufacturing of medical cannabis with an emphasis on quality and safety. Tilray Brands offers various forms of cannabis products, including therapeutic oil, capsules, flowers, and other preparations designed for medicinal purposes. The company collaborates with physicians and patients to provide high-quality and effective treatment options for various medical conditions. Tilray Brands is also engaged in research and development of new cannabis medicines and therapies. The company is following the growing interest in medicinal cannabis and its potential to improve the health of patients. Tilray Brands, Inc. (TLRY or TLB) shares could be an interesting choice for investors who follow the market for medicinal cannabis products and seek investment opportunities in an international company with a specialized focus on medical cannabis.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
3,595
Headquarters
Leamington
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Analysts expect revenue to grow by 20% this fiscal year.
- What to watch: It missed profit estimates 6 times in the last 8 quarters.
- What to watch: Revenue growth is slowing: 2.7% a year over the last 3 years against 8.1% over 5 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number